P3 Health Partners Inc. Class A PIII 深 沪
等待开盘 04-02 09:30:00 美东时间
2.74
-0.340
-11.04%
华盛通- 最 高3.12
- 今 开3.12
- 成交量 1.48万股
- 最 低 2.72
- 昨 收 3.08
- 总市值 1976.48万
- 52周最高 11.30
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 1.52
- 委 比 43.06%
- 总股本 721.34万
- 历史最高 836.50
- 量 比 0.57
- 振 幅 12.99%
- 历史最低 1.52
- 每 手 1
- 风险率 2.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
03-30 11:49
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.
03-27 23:03
P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est
P3 Health Partners (NASDAQ:PIII) sees FY2026 sales of $1.500 billion-$1.700 billion vs $1.645 billion analyst estimate.
03-27 04:13
P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate
P3 Health Partners (NASDAQ:PIII) reported quarterly losses of $(23.02) per share which missed the analyst consensus estimate of $(9.46) by 143.21 percent. This is a 18.05 percent decrease over losses of $(19.50) per
03-27 04:12
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Edesa Biotech (NASDAQ:EDSA) shares rose 61.0% to $3.67 during Tuesday'...
03-04 01:05
P3 Health Partners, Commonwealth Primary Care Form JV For ACO Lines Of Businesses To Expand Value-Based Care, Enhance Support For Primary Care Physicians Throughout Arizona, California, Nevada, Oregon, and North Carolina
P3 Health Partners ("P3") (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed
2025-12-03 05:11
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $12.5
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.
2025-11-18 01:33
